Priya A. Singhal is a distinguished leader in the biotechnology industry, currently serving as the Head of Development at BIOGEN INC. With an illustrious career spanning over two decades, Priya has made significant contributions to the field of medical research and development. She holds a Doctorate in Molecular Biology from Stanford University and has completed advanced management training at Harvard Business School. Prior to joining BIOGEN, Priya held pivotal roles at major pharmaceutical companies such as Pfizer and Novartis, where she spearheaded numerous successful drug development programs. In her current role at BIOGEN, Priya oversees the entire development pipeline, from early-stage research to late-phase clinical trials. Her strategic vision and leadership have been instrumental in advancing BIOGEN's mission to discover and deliver innovative therapies for neurological and neurodegenerative diseases. Under her guidance, the company has seen several breakthrough treatments reach the market, significantly impacting the lives of patients worldwide. Priya's commitment to scientific excellence and patient-centric innovation has earned her numerous accolades, including the prestigious Innovator of the Year award from the Biotechnology Innovation Organization. Beyond her professional achievements, Priya is a passionate advocate for diversity and inclusion in the STEM fields. She actively mentors young scientists and serves on the board of several non-profit organizations dedicated to promoting education and career opportunities for underrepresented groups in science and technology. Her holistic approach to leadership not only drives BIOGEN's success but also fosters a culture of inclusivity and innovation within the industry.